This white paper shows how to develop, execute and manage the transformation, analysis and submission of clinical research data with SAS® Drug Development. It includes an executive summary that outlines current industry challenges. And, it answers the top ten questions life sciences executives confront when trying to balance innovation with regulatory compliance.
Concise Executive Guide to Business Analytics: Overview of business applications and payoffs, staff and technology requirements, and the roles executives must play to realize the performance potential of analytics. Six key questions are asked about how well information at hand is used to meet goals and innovate in the marketplace.
Because of their investment in intellectual property and the clinical trial information they generate, life sciences companies face greater security risks than other companies. This paper explores common business processes that put companies at risk and ways companies protect themselves.